These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

861 related articles for article (PubMed ID: 19289703)

  • 1. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
    Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
    Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
    Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
    Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and clinical significance of TESTIN in primary gastric cancer].
    Huang W; Weng DS; Pan ZZ; Pan K; Ding PR; Zhou J; Wang H; Zhang HK; Li JJ; Xia JC
    Ai Zheng; 2008 Sep; 27(9):984-8. PubMed ID: 18799041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
    Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
    Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
    Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
    Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
    Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
    Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
    J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
    Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
    Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
    Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
    Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
    Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
    Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
    Edström S; Cvetkovska E; Westin T; Young C
    Laryngoscope; 2001 Jan; 111(1):124-30. PubMed ID: 11192880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
    Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
    Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of RAD17 in head and neck cancer.
    Zhao M; Begum S; Ha PK; Westra W; Califano J
    Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of signal transducers and activators of transcription 3 and overexpression of its target gene CyclinD1 in laryngeal carcinomas.
    Liu B; Ren Z; Shi Y; Guan C; Pan Z; Zong Z
    Laryngoscope; 2008 Nov; 118(11):1976-80. PubMed ID: 18758380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.